ISSN: 2329-9495
+44 1478 350008
Department of Critical Care Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, 510000, Guangdong Province, China
Research Article
Oral Soluble Guanylate Cyclase Stimulators in Heart Failure: A Meta-Analysis of Randomized Controlled Trials
Author(s): Qiang Ren, Quanyu Zhang* and Sicong Ma*
Background: The impact of Guanylate Cyclase (sGC) stimulators on clinical outcomes of HF patients were still controversial.
Objectives: To investigate the efficacy and safety of oral soluble sGC stimulators in Heart Failure (HF).
Methods: PubMed, Web of Science, and Cochrane Library were searched to identify Randomized Controlled Trials (RCTs) comparing sGC stimulators vs placebo in HF patients. A total of 6 RCTs with 7382 HF patients were included.
Results: Compared with placebo, oral sGC stimulators reduced the risk of a composite of Cardiovascular (CV) death or Hospitalization for HF (HHF), Odd’s Ratio (OR) 0.87, 95% Confidence Interval (CI) 0.78-0.98, p=0.02), and CV death [OR 0.45, 95% CI 0.38-0.53, p<0.001]. Significant reduction in the CV death [OR 0.42, 95% .. View More»